TNP-2092 capsules
TNP-2092-03
Phase 1 small_molecule completed
Quick answer
TNP-2092 capsules for Helicobacter Pylori Infection is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Helicobacter Pylori Infection
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed